Organic Anion Transporters
-
Subject Areas on Research
- Clinical application of cardiovascular pharmacogenetics.
- Community pharmacists' experience with pharmacogenetic testing.
- Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria.
- Differential expression of GABA and glutamate-receptor subunits and enzymes involved in GABA metabolism between electrophysiologically identified hippocampal CA1 pyramidal cells and interneurons.
- Effect of citrus juice and SLCO2B1 genotype on the pharmacokinetics of montelukast.
- Effect of genetic variations on ticagrelor plasma levels and clinical outcomes.
- Enteric microbiome metabolites correlate with response to simvastatin treatment.
- Genome-wide study of methotrexate clearance replicates SLCO1B1.
- Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum binding.
- Indoxyl sulfate down-regulates SLCO4C1 transporter through up-regulation of GATA3.
- SLCO1B1 genetic variants, long-term low-density lipoprotein cholesterol levels and clinical events in patients following cardiac catheterization.
- SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation.
- Sodium-hydrogen exchanger regulatory factor-1 interacts with mouse urate transporter 1 to regulate renal proximal tubule uric acid transport.
- The SLCO1B1*5 genetic variant is associated with statin-induced side effects.
- The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.
- The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.
- The mitochondrial citrate/isocitrate carrier plays a regulatory role in glucose-stimulated insulin secretion.